Effect of Pharmacy Involvement in Transitions of Care for Children With Medical Complexity.
Journal
The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG
ISSN: 1551-6776
Titre abrégé: J Pediatr Pharmacol Ther
Pays: United States
ID NLM: 101089851
Informations de publication
Date de publication:
2023
2023
Historique:
received:
09
07
2022
accepted:
13
09
2022
medline:
5
10
2023
pubmed:
5
10
2023
entrez:
5
10
2023
Statut:
ppublish
Résumé
The purpose of this study is to evaluate the effects of pharmacy integration into care transitions for children with medical complexity. These children are at a higher risk for medication errors and adverse effects because of their complex medication regimens. In addition, care transitions increase the risk for medication errors, especially during hospital-to-home transitions. This was a retrospective chart review of patients enrolled in a complex care clinic who were discharged between September 1, 2021, and December 31, 2021, and who had received a discharge medication evaluation. Intervention categories were predetermined (medication reconciliation and clinical interventions) and documented. The primary outcome was to quantify and characterize the types of interventions made by the pharmacist. Descriptive statistics were used for data analysis. Continuous data were analyzed using Wilcoxon rank sum test, and correlation was measured using Spearman correlation values. A total of 92 clinic encounters for 60 patients were included, with a median patient age of 7 years (IQR, 5-12.3), median length of stay of 3.2 days (IQR, 1.2-5.7), and a median number of 18 discharge medications (IQR, 14.8-25). A total of 283 interventions were made, consisting of 192 (68%) clinical interventions and 91 (32%) medication reconciliation interventions. In addition, 82 (89%) of the clinic encounters had at least one pharmacist intervention. Pharmacist evaluation of a patient's discharge medication regimen clarifies and better optimizes the patient's medication regimen.
Identifiants
pubmed: 37795275
doi: 10.5863/1551-6776-28.4.348
pmc: PMC10547039
doi:
Types de publication
Journal Article
Langues
eng
Pagination
348-353Informations de copyright
Copyright. Pediatric Pharmacy Association. All rights reserved. For permissions, email: membership@pediatricpharmacy.org.
Déclaration de conflit d'intérêts
Disclosures. Alannah Yoder was affiliated with Children’s Mercy Hospital as noted above; employment is now at Novo Nordisk Inc. The publication is written in her capacity, not on behalf of Novo Nordisk Inc. (Business address: 900 Scudders Mill Road, Plainsboro, NJ 08536). The other authors declare no conflicts or financial interest in any product or service mentioned in the manuscript, including grants, equipment, medications, employment, gifts, and honoraria. The authors had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Références
Ann Pharmacother. 2004 Sep;38(9):1369-76
pubmed: 15266038
Pediatrics. 2017 Jan;139(1):
pubmed: 27940509
Arch Dis Child. 2010 Apr;95(4):250-5
pubmed: 19948664
JAMA. 2001 Apr 25;285(16):2114-20
pubmed: 11311101
JAMA Netw Open. 2021 Aug 2;4(8):e2122818
pubmed: 34436607
Pharmacotherapy. 2014 Aug;34(8):826-35
pubmed: 24947636
J Pediatr Pharmacol Ther. 2017 Jul-Aug;22(4):246-250
pubmed: 28943817
J Patient Saf. 2014 Dec;10(4):186-91
pubmed: 25408236
Ann Pharmacother. 2014 Jan;48(1):26-32
pubmed: 24259639
Clin Ther. 2013 Apr;35(4):385-398.e1
pubmed: 23541707
Pediatrics. 2012 Dec;130(6):e1463-70
pubmed: 23184117
Jt Comm J Qual Patient Saf. 2019 Aug;45(8):536-542
pubmed: 30898508
Pediatrics. 2014 Jun;133(6):e1575-85
pubmed: 24843054
Pediatrics. 2011 Mar;127(3):529-38
pubmed: 21339266